Cercare Medical A/S

Public limited companyCVR 35483489Aarhus CActive

Cercare Medical A/S is a public limited company, based in Aarhus C, active in research and experimental development on natural sciences and engineering, founded in 2013. Equity was negative at the end of 2025 (−DKK 11.3m). The company made a loss in both 2024 and 2025, most recently DKK 56.7m. With 28 employees, the company is about 6 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 33.3m−5.2% vs. 2024
Net profit−DKK 56.7m−6.5% vs. 2024
Equity−DKK 11.3m−136.6% vs. 2024
Employees28latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 53.3m to DKK 56.7m (2024 → 2025).
  • Equity turned negative: −DKK 11.3m (2024 → 2025).

Management and owners, last 24 months

  • New in management: Belinda Jane Oakland (board member, 01/04/2026).
  • New owners registered: MK Holding af 2013 ApS (30/01/2025) and Smedvig Capital AS (19/05/2026).
  • No longer registered as owner: MK Holding af 2013 ApS (29/01/2025), Smedvig Capital AS (18/05/2026) and Herfo FInans AS (22/11/2024) (+1).

Registrations, last 24 months

  • 19/05/2026: Share capital changed from 1,307,253 DKK to 1,454,815 DKK
  • 01/04/2026: Share capital changed from 1,000,918 DKK to 1,307,253 DKK
  • 30/01/2025: Share capital changed from 957,826 DKK to 1,000,918 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 10/12/2024: Share capital changed from 931,484 DKK to 957,826 DKK
  • 22/11/2024: Share capital changed from 775,641 DKK to 931,484 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 60m−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40m202020212022202320242025
EquityNet profit
Financial figures for Cercare Medical A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−2,8523,045−18,800−24,371−31,642−33,296−5.2%
Operating profit (EBIT)−16,599−12,304−34,528−43,380−54,879−58,908−7.3%
Profit before tax−16,752−12,522−34,943−45,168−56,120−59,347−5.7%
Net profit−14,654−10,858−31,927−42,425−53,285−56,743−6.5%
Total assets43,27337,7709,35926,54136,60019,269−47.4%
Equity40,80835,537−3,82519,85530,829−11,270−136.6%
Liabilities2,4662,23313,1846,6865,77230,538+429.1%
Cash and cash equivalents38,7603,2513,79519,83930,95614,372−53.6%
Average number of employees1617–222627+3.8%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 35m−DKK 30m−DKK 25m−DKK 20m−DKK 15m−DKK 10m−DKK 5mDKK 0DKK 5m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 11.3m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Cercare Medical A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202403/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202329/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202205/07/2023The companyPDFXBRL
202101/01/2021 – 31/12/202129/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202002/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05101520253008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 33.3mNo. 413 of 421
Better than 2% of the companies in the industry
Equity−DKK 11.3mNo. 405 of 431
Better than 6% of the companies in the industry
Number of employees28No. 71 of 431
Better than 84% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 9,876of 9,892
Better than 0%
No. 9,800of 9,922
Better than 1%
Same industry and 20–49 employees64 companies in the comparison
No. 58of 62
Better than 7%
No. 54of 64
Better than 16%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,565of 33,588
Better than 0%
No. 33,387of 33,687
Better than 1%
All companies of type A/S18,025 companies in the comparison
No. 17,750of 17,786
Better than 0%
No. 17,806of 18,024
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Cercare Medical A/S−DKK 33.3m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Cercare Medical A/S−DKK 56.7m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Cercare Medical A/S−DKK 11.3m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Cercare Medical A/S28
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Cercare Medical A/S

Management

7 active registrations

Executive management

Executive management at Cercare Medical A/S
NameRoleAppointed
Kim Beuschau MouridsenCEO01/04/2021

Board of directors

Board of directors at Cercare Medical A/S
NameRoleAppointed
Mikkel Bo HansenBoard member03/10/2013
Marit SalteBoard member28/10/2016
Jeppe Øvli ØvlesenChair of the board01/04/2021
Jonathan Andrew LernerBoard member30/06/2023
Ulla Bagger-SørensenBoard member01/07/2023
Belinda Jane OaklandBoard member01/04/2026
Founders
MK Holding af 2013 ApS
Former management (12)
Former management at Cercare Medical A/S
NameRoleAppointedResigned
Kim Beuschau MouridsenBoard member27/09/201301/04/2021
Kim Beuschau MouridsenDirector27/09/201328/10/2016
Jon Ingi BenediktssonChair of the board03/10/201301/04/2016
Jeppe Øvli ØvlesenBoard member29/11/201328/10/2016
Jeppe Øvli ØvlesenDirector28/10/201622/10/2017
Odd TorlandBoard member28/10/201622/10/2017
Jeppe Øvli ØvlesenCEO23/10/201701/04/2021
Odd TorlandChair of the board23/10/201731/03/2021
Kim Beuschau MouridsenDirector06/04/201831/03/2021
Aitana Peire MoraisBoard member30/09/202028/04/2022
Odd TorlandBoard member01/04/202130/06/2023
Konstantinos DimitrakopoulosBoard member28/04/202231/12/2023

Signing rule: Selskabet tegnes af tre medlemmer af bestyrelsen i forening eller af Selskabets administrerende direktør og bestyrelsesformanden i forening.

Address and production units

1 active production units

Inge Lehmanns Gade 10
8000 Aarhus C

Aarhus Municipality · Postcode 8000

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Cercare Medical A/SInge Lehmanns Gade 10, 8000 Aarhus C301018788116

Purpose

Selskabets formål er at drive en virksomhed til udvikling, handel og salg af computer baseret beslutningsstøtteværktøj til brug i kliniske omgivelser og til at estimere omfanget af salvageable væv hos patienter med akut iskæmisk slagtilfælde, og andre beslægtede aktiviteter.

The purpose is quoted from the register in Danish.

Changes year by year

120 registered events
20266 changesaccounts 1 · capital 2 · ownership 2 · management 1
  • Annual report for 2025 published
  • Share capital changed from 1,307,253 DKK to 1,454,815 DKK
  • Smedvig Capital AS registered as owner (25%)
  • Smedvig Capital AS is no longer registered as owner
  • Share capital changed from 1,000,918 DKK to 1,307,253 DKK
  • Belinda Jane Oakland appointed board member
20255 changesaccounts 1 · capital 1 · ownership 2 · industry 1
  • Annual report for 2024 published
  • Share capital changed from 957,826 DKK to 1,000,918 DKK
  • MK HOLDING AF 2013 ApS registered as owner (5%)
  • MK HOLDING AF 2013 ApS is no longer registered as owner
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202410 changescapital 3 · ownership 5 · accounts 1 · address 1
  • Share capital changed from 931,484 DKK to 957,826 DKK
  • Share capital changed from 775,641 DKK to 931,484 DKK
  • Quantass ApS is no longer registered as owner
  • Herfo FInans AS is no longer registered as owner
  • Bagger-Sørensen Equity A/S registered as owner (5%)
  • Tablet 8 ApS is no longer registered as owner
  • Annual report for 2023 published
  • Share capital changed from 761,610 DKK to 775,641 DKK
  • Quantass ApS registered as owner (5%)
  • Moved to Inge Lehmanns Gade 10, 8000 Aarhus C
202316 changesmanagement 4 · accounts 1 · capital 2 · ownership 9
  • Konstantinos Dimitrakopoulos stepped down as board member
  • Annual report for 2022 published
  • Share capital changed from 486,845 DKK to 761,610 DKK
  • Ulla Bagger-Sørensen appointed board member
  • MK HOLDING AF 2013 ApS registered as owner (10%)
  • Tablet 8 ApS registered as owner (5%)
  • Canica Holding AG registered as owner (5%)
  • Herfo FInans AS registered as owner (5%)
  • Smedvig Capital AS registered as owner (33.33%)
  • Quantass ApS is no longer registered as owner
  • Jonathan Andrew Lerner appointed board member
  • Odd Torland stepped down as board member
  • MK HOLDING AF 2013 ApS is no longer registered as owner
  • Canica Holding AG is no longer registered as owner
  • Smedvig Capital AS is no longer registered as owner
  • Share capital changed from 485,373 DKK to 486,845 DKK
20223 changesaccounts 1 · management 2
  • Annual report for 2021 published
  • Konstantinos Dimitrakopoulos appointed board member
  • Aitana Peire Morais stepped down as board member
202116 changesaccounts 1 · capital 1 · ownership 7 · management 7
  • Annual report for 2020 published
  • Share capital changed from 475,452 DKK to 485,373 DKK
  • MK HOLDING AF 2013 ApS registered as owner (15%)
  • Canica Holding AG registered as owner (5%)
  • Smedvig Capital AS registered as owner (33.33%)
  • Quantass ApS registered as owner (5%)
  • Smedvig Capital AS is no longer registered as owner
  • Canica Holding AG is no longer registered as owner
  • MK HOLDING AF 2013 ApS is no longer registered as owner
  • Odd Torland appointed board member
  • Kim Beuschau Mouridsen appointed ceo
  • Jeppe Øvli Øvlesen appointed chair of the board
  • Jeppe Øvli Øvlesen stepped down as ceo
  • Kim Beuschau Mouridsen stepped down as board member
  • Kim Beuschau Mouridsen stepped down as director
  • Odd Torland stepped down as chair of the board
202015 changesname 1 · ownership 10 · capital 3 · management 1
  • Name changed from Cercare Medical ApS to Cercare Medical A/S
  • QUANTASS ApS is no longer registered as owner
  • Share capital changed from 457,317 DKK to 475,452 DKK
  • Smedvig Capital AS registered as owner (33.33%)
  • Smedvig Capital AS is no longer registered as owner
  • Share capital changed from 396,831 DKK to 457,317 DKK
  • Aitana Peire Morais appointed board member
  • Canica Holding AG registered as owner (5%)
  • Share capital changed from 352,792 DKK to 396,831 DKK
  • MK HOLDING AF 2013 ApS registered as owner (20%)
  • Smedvig Capital AS registered as owner (50%)
  • QUANTASS ApS registered as owner (5%)
  • Smedvig Capital AS is no longer registered as owner
  • MK HOLDING AF 2013 ApS is no longer registered as owner
  • QUANTASS ApS is no longer registered as owner
20191 changecapital 1
  • Share capital changed from 312,797 DKK to 352,792 DKK
201815 changesaddress 3 · capital 2 · ownership 9 · management 1
  • Moved to Inge Lehmanns Gade 10, 8000 Aarhus C
  • Moved to Inge Lehmanns Gade 10, 8000 Aarhus C
  • Share capital changed from 294,364 DKK to 312,797 DKK
  • Smedvig Capital AS registered as owner (33.33%)
  • Cercare Medical A/S is no longer registered as owner
  • SALK HOLDING ApS is no longer registered as owner
  • Smedvig Capital AS is no longer registered as owner
  • Kim Beuschau Mouridsen appointed director
  • Share capital changed from 278,980 DKK to 294,364 DKK
  • MK HOLDING AF 2013 ApS registered as owner (25%)
  • Smedvig Capital AS registered as owner (25%)
  • Cercare Medical A/S registered as owner (5%)
  • Smedvig Capital AS is no longer registered as owner
  • MK HOLDING AF 2013 ApS is no longer registered as owner
  • Moved to Inge Lehmanns Gade 10, 8000 Aarhus C
20177 changesownership 1 · capital 1 · name 1 · management 4
  • CORPORATE CULTURE ApS is no longer registered as owner
  • Share capital changed from 258,980 DKK to 278,980 DKK
  • Name changed from COMBAT STROKE ApS to Cercare Medical ApS
  • Jeppe Øvli Øvlesen appointed ceo
  • Odd Torland appointed chair of the board
  • Odd Torland stepped down as board member
  • Jeppe Øvli Øvlesen stepped down as director
201615 changesmanagement 6 · capital 2 · ownership 7
  • Marit Salte appointed board member
  • Odd Torland appointed board member
  • Jeppe Øvli Øvlesen appointed director
  • Jeppe Øvli Øvlesen stepped down as board member
  • Kim Beuschau Mouridsen stepped down as director
  • Share capital changed from 166,127 DKK to 258,980 DKK
  • SALK HOLDING ApS registered as owner (5%)
  • Smedvig Capital AS registered as owner (20%)
  • QUANTASS ApS registered as owner (5%)
  • MK HOLDING AF 2013 ApS registered as owner (33.33%)
  • MK HOLDING AF 2013 ApS is no longer registered as owner
  • Share capital changed from 110,127 DKK to 166,127 DKK
  • CORPORATE CULTURE ApS registered as owner (10%)
  • PreSeed Ventures A/S is no longer registered as owner
  • Jon Ingi Benediktsson stepped down as chair of the board
20143 changescapital 1 · ownership 2
  • Share capital changed from 102,433 DKK to 110,127 DKK
  • MK HOLDING AF 2013 ApS registered as owner (66.67%)
  • PreSeed Ventures A/S registered as owner (20%)
20138 changesmanagement 5 · capital 1 · address 1 · founded 1
  • Jeppe Øvli Øvlesen appointed board member
  • Share capital changed from 80,000 DKK to 102,433 DKK
  • Jon Ingi Benediktsson appointed chair of the board
  • Mikkel Bo Hansen appointed board member
  • Moved to Nørrebrogade 44, 5. th, 8000 Aarhus C
  • Registered as COMBAT STROKE ApS
  • Kim Beuschau Mouridsen appointed director
  • Kim Beuschau Mouridsen appointed board member

Related companies

Same industry in Aarhus

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction